February 2026
The global metabolomics biomarker market size was evaluated at USD 3.30 billion in 2025 and is predicted to hit around USD 10.85 billion by 2035, growing at a CAGR of 12.64%.
July 2026
The global cancer biomarkers market size was estimated at USD 15.58 billion in 2025 and is projected to hit around USD 47.14 billion by 2035 with a CAGR of 11.71%.
July 2026
The global digital biomarkers market size calculated at USD 5.04 billion in 2025 and is projected to hit around USD 36.98 billion by 2035 with a CAGR of 22.05%.
July 2026
The orphan disease biomarkers market expands with advancements in genomics, proteomics, and bioinformatics for rare conditions.
June 2026
The global circulating biomarkers market size is estimated to hit around USD 15.62 billion by 2035 increasing from USD 5.17 billion in 2025, with a CAGR of 11.69%.
June 2026
The global genomic biomarker market size was valued at USD 6.04 billion in 2025 and is projected to reach around USD 11.63 billion by 2035, registering a notable CAGR of 6.77%.
June 2026
The global proteomic biomarkers market size is growing as advanced proteomics enhances disease diagnosis, prognosis, and personalized therapy.
June 2026
The global biomarker discovery outsourcing services market size is evaluated at USD 17.42 billion in 2025 and is predicted to hit around USD 99.38 billion by 2035, growing at a CAGR of 19.02%.
June 2026
The global predictive biomarkers market size is valued at USD 28.88 billion in 2025 and is predicted to hit around USD 155.53 billion by 2035, at a CAGR of 18.34%.
May 2026
The global biomarkers market size was valued at USD 94.24 billion in 2025 and is expected to hit around USD 355.72 billion by 2035 with a CAGR of 14.21%.
May 2026
The global multiplex biomarker imaging market size is projected to hit around USD 1,780.14 million by 2035 from USD 588.93 million in 2025 with a CAGR of 11.70%.
May 2026
The global CNS biomarkers market size was evaluated at USD 7.80 billion in 2025 and is predicted to hit around USD 26.13 billion by 2035, growing at a CAGR of 12.90%.
May 2026
The neurological biomarkers market size reached USD 10.32 billion in 2025 and is projected to surpass around 34.02 billion by 2035, with a solid CAGR of 12.67%.
May 2026
The global Parkinsons disease biomarkers market size was evaluated at USD 1.35 billion in 2025 and is predicted to hit around USD 4.88 billion by 2035, growing at a CAGR of 13.80%.
February 2026
The global veterinary biomarkers market size is estimated to hit around USD 4.13 billion by 2035 increasing from USD 1.24 billion in 2025, with a CAGR of 12.79%.
January 2026
The global personalized medicine biomarkers market size is projected to hit around USD 92.22 billion by 2035 from USD 22.04 billion in 2025 with a CAGR of 15.39%.
September 2025
The global AI-enabled non-invasive biomarker sensors market is growing as AI-powered sensors transform disease detection, monitoring, and personalized healthcare.
September 2025
The global metabolomics market size was evaluated at USD 3.77 billion in 2024 and is predicted to hit around USD 14.40 billion by 2034, growing at a CAGR of 14.34%.
August 2025
The renal biomarkers market size was evaluated at USD 1.62 billion in 2024 and is projected to attain around USD 3.57 billion by 2034, with a solid CAGR of 8.22%.
August 2025
The global cardiac biomarkers market size reached USD 21.20 billion in 2024 and is projected to surpass around USD 82.99 billion by 2034, with a remarkable CAGR of 14.62%.
July 2026
The omics sequencing market is driven by rising demand for precision medicine, drug discovery, and advanced genomics research across healthcare and biotechnology.
July 2025
The global in-vitro inflammatory bowel disease diagnostics market size was valued at USD 1.74 billion in 2024 and is expected to hit around USD 3.02 billion by 2034, at a CAGR of 5.64%.
July 2025
The global human biospecimens market size was evaluated at USD 12.42 billion in 2024 and is predicted to hit around USD 26.45 billion by 2034, growing at a CAGR of 7.85%.
July 2025
Explore the checkpoint inhibitor drugs market, driven by rising cancer prevalence, expanding indications for PD-1/PD-L1 and CTLA-4 inhibitors, and advancements in immuno-oncology therapies.
July 2025
Explore the pan-tumor oncology treatment market, driven by breakthroughs in immunotherapy, targeted treatments, and the rise of tumor-agnostic drug approvals across multiple cancer types.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com